Enhanced anti-tumor effect of combination therapy with anti-CD40 antibody and the mTOR kinase inhibitor AZD8055

被引：0
作者：
Jiang, Qun
Weiss, Jonathan M.
Ortaldo, John R.
Back, Timothy
Guichard, Sylvie
Thakurta, Anjan
Wiltrout, Robert H.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-5596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5596
引用
收藏
页数：3
相关论文
共 50 条
[21]   Enhanced anti-tumor effect of trastuzumab in combination with cisplatin [J].
Naruse, I ;
Fukumoto, H ;
Saijo, N ;
Nishio, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (05) :574-581
[22]   Extracellular matrix-binding form of anti-CD40 agonistic antibody reduces systemic damages and increases anti-tumor efficacy. [J].
Ishihara, A. ;
Ishihara, J. ;
Fukunaga, K. ;
Hubbell, J. A. .
MOLECULAR BIOLOGY OF THE CELL, 2017, 28
[23]   Enhanced anti-tumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer [J].
Ahn, D-W ;
Seo, J. K. ;
Lee, S. H. ;
Hwang, J-H ;
Lee, J. K. ;
Ryu, J. K. ;
Kim, Y-T ;
Yoon, Y. B. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 :241-241
[24]   Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer [J].
Lee, Sang Hyub ;
Ryu, J. Kon ;
Lee, Kyeung-Yeup ;
Woo, Sang Myung ;
Park, Joo Kyung ;
Yoo, Ji Won ;
Kim, Yong-Tae ;
Yoon, Yong Bum .
CANCER LETTERS, 2008, 259 (01) :39-49
[25]   EFFECT AND SAFETY OF ANTI-CD40 ANTIBODY ON THE SURVIVAL OF CORNEAL XENOTRANSPLANTATION. [J].
Kim, Jaeyoung ;
Kim, Dong Hyun ;
Choi, Hyuk Jin ;
Lee, Hyun Ju ;
Kim, Ji Hyun ;
Kang, Hee Jung ;
Park, Chung-Gyu ;
Wee, Won Ryang ;
Kim, Mee Kum .
TRANSPLANTATION, 2015, 99 (11) :S83-S83
[26]   Potent anti-tumor activity of mTOR kinase inhibitor in combination with anti-angiogenic agents in preclinical models of renal cell cancer [J].
Wang, Shunyou ;
Lan, Lucy ;
Janes, Mathew ;
Jessen, Katti ;
Kessler, Linda ;
Kucharski, Jeff ;
Guo, Xin Xin ;
Staunton, Jocelyn ;
Elia, Marikka ;
Banerjee, Urmi ;
Stewart, Josh ;
Dartania, Levan ;
Li, Liansheng ;
Chan, Katrina ;
Martin, Mike ;
Ren, Pingda ;
Rommei, Christian ;
Liu, Yi .
CANCER RESEARCH, 2012, 72
[27]   Anti-CD40 monoclonal antibody therapy: Treatment toxicity and implications for cancer immunotherapy [J].
Geldart, T ;
Harvey, M ;
Carr, N ;
Glennie, M ;
Johnson, P .
BRITISH JOURNAL OF CANCER, 2003, 88 :S36-S36
[28]   Long term Effect of anti-CD40 antibody treatment on the survival of corneal xenotransplantation [J].
Kim, Mee Kum ;
Kim, Jaeyoung ;
Kim, Dong Hyun ;
Choi, Hyuk Jin ;
Lee, Hyun Ju ;
Jeong, Hyun Jeong ;
Kang, Hee Jung ;
Park, Chung-Gyu ;
Wee, Won Ryang .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[29]   Agonistic Anti-CD40 Antibody Therapy is Effective Against Postoperative Cancer Recurrence and Metastasis in a Murine Tumor Model [J].
Khong, Andrea ;
Brown, Matthew D. ;
Vivian, Justin B. ;
Robinson, Bruce W. S. ;
Currie, Andrew J. .
JOURNAL OF IMMUNOTHERAPY, 2013, 36 (07) :365-372
[30]   Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine [J].
Chang, Ming-Cheng ;
Chen, Yu-Li ;
Chiang, Ying-Cheng ;
Cheng, Ya-Jung ;
Jen, Yu-Wei ;
Chen, Chi-An ;
Cheng, Wen-Fang ;
Sun, Wei-Zen .
AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (02) :157-172
12345